We herein aimed to build up a multigene-based model that is eligible as prognostic for patients with advanced stage of serous ovarian carcinoma and to define novel key AID/APOBEC-associated aspects of ovarian cancer. This evidence concerns the gene AICDA and ovarian carcinoma.